Earnings Preview For BioDelivery Sciences Intl

Comments
Loading...

On Wednesday, August 04, BioDelivery Sciences Intl BDSI will release its latest earnings report. Decipher the announcement with Benzinga's help.

Net Income, Earnings, And Earnings Per Share

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Analysts covering BioDelivery Sciences Intl modeled for quarterly EPS of $0.05 on revenue of $42.41 million. BioDelivery Sciences Intl reported a profit of $0.09 per share when it published results during the same quarter last year. Sales in that period totaled $36.58 million.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

If the company were to report earnings in line when it publishes results Wednesday, earnings would be down 44.44%. Revenue would be have grown 15.93% from the same quarter last year. Here is how the company's reported EPS has stacked up against analyst estimates in the past:

Quarter Q1 2021 Q4 2020 Q3 2020 Q2 2020
EPS Estimate 0.07 0.06 0.05 0.04
EPS Actual 0.05 0.10 0.09 0.09
Revenue Estimate 41.34 M 38.72 M 39.35 M 36.44 M
Revenue Actual 41.02 M 42.17 M 39.44 M 36.58 M

eps graph

Want Real-Time Earnings Calendar Updates?

Benzinga consistently updates its earnings calendars to stay up-to-date with the latest company earnings reports. Check out the full earnings calendar list updated in real-time by following this link.

Stock Performance

Over the past 52-week period, shares of BioDelivery Sciences Intl have declined 11.37%. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. BioDelivery Sciences Intl is scheduled to hold the call at 08:30:00 ET and can be accessed here.

Market News and Data brought to you by Benzinga APIs

Posted In: